STATE STREET CORP

Position in CLDX — Celldex Therapeutics, Inc.

CIK 93751 BOSTON, MA

Back to CLDX Full portfolio

Position in CLDX

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$145,134,888

+$56,186,680 QoQ

Shares Held

3,900,427

+39.1% QoQ

Ownership

4.97%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

of 252 holders

Holding Since

Sep 2020

24 quarters on record

Voting authority Sole 11% Shared 0% None 89%

Common Shares in CLDX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

STATE STREET CORP holds $36,552,510,511 across 411 Biotechnology names. CLDX ranks #61 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	11,871,459	$5,896,909,829
2	REGN	Regeneron Pharmaceuticals, Inc.	4,834,688	$3,014,621,355
3	INCY	Incyte Corp	9,722,336	$1,102,124,008
4	MRNA	Moderna, Inc.	15,726,193	$1,101,305,295
5	ALNY	Alnylam Pharmaceuticals, Inc.	3,555,689	$1,070,369,059
6	RVMD	Revolution Medicines, Inc.	4,897,051	$917,119,711
7	RPRX	Royalty Pharma plc	12,338,229	$691,804,500
8	INSM	INSMED Inc	6,052,174	$645,282,791

All Filings in CLDX

Export CSV

26 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$145,134,888	3,900,427	+39.1%	Shares	Defined	2026-08-07
2026-03-31	$88,948,208	2,804,168	-17.5%	Shares	Sole	2026-05-12
2026-03-31	$88,948,208	2,804,168	-17.5%	Shares	Defined	2026-05-15
2025-12-31	$92,281,885	3,397,713	+19.5%	Shares	Defined	2026-02-13
2025-12-31	$92,281,885	3,397,713	—	Shares	Sole	2026-02-09
2025-09-30	$73,526,006	2,842,134	+18.2%	Shares	Defined	2025-11-14
2025-06-30	$48,951,823	2,405,495	-14.3%	Shares	Defined	2025-08-14
2025-03-31	$50,935,415	2,806,359	-13.2%	Shares	Defined	2025-05-15
2024-12-31	$81,747,464	3,234,961	+30.2%	Shares	Defined	2025-02-14
2024-09-30	$84,470,452	2,485,156	-6.5%	Shares	Defined	2024-11-14
2024-06-30	$98,412,846	2,659,088	-10.8%	Shares	Defined	2024-08-14
2024-03-31	$125,060,149	2,979,751	+25.3%	Shares	Defined	2024-05-15
2023-12-31	$94,284,749	2,377,326	+3.7%	Shares	Defined	2024-02-14
2023-09-30	$63,099,259	2,292,851	-15.9%	Shares	Defined	2023-11-14
2023-06-30	$92,537,492	2,727,306	+18.4%	Shares	Defined	2023-08-14
2023-03-31	$82,844,849	2,302,525	+0.5%	Shares	Defined	2023-05-15
2022-12-31	$102,130,104	2,291,454	-27.8%	Shares	Defined	2023-05-15
2022-09-30	$89,153,057	3,171,578	-1.8%	Shares	Defined	2022-11-15
2022-06-30	$87,049,849	3,228,852	+20.4%	Shares	Defined	2022-08-15
2022-03-31	$91,373,715	2,682,728	+13.3%	Shares	Defined	2022-05-16
2021-12-31	$91,501,065	2,368,040	+27.5%	Shares	Defined	2022-02-14
2021-09-30	$100,265,800	1,857,118	-11.3%	Shares	Defined	2021-11-15
2021-06-30	$70,030,649	2,094,218	+11.6%	Shares	Defined	2021-08-16
2021-03-31	$38,665,726	1,876,977	+3.7%	Shares	Defined	2021-07-09
2020-12-31	$31,715,755	1,810,260	+7030.7%	Shares	Defined	2021-02-16
2020-09-30	$376,489	25,387	—	Shares	Defined	2020-11-10
No filing history on record for this holder in this stock.